The Food and Drug Administration has approved a new pain medication that could take the place of opioids for those experiencing moderate to severe acute pain. The drug is Journavx, or the generic name ...

Navitus today released its 10 th annual Drug Trend Report, “Clarity for Action,” the company’s flagship annual analysis of ...

Pharmaceutical company Novo Nordisk is pursuing legal action against two compounding pharmacies for allegedly offering contaminated copycat versions of the drug semaglutide, found in weight-loss ...

In today’s healthcare system, we stand at a critical crossroads when it comes to medication management. For decades, the practice of polypharmacy — prescribing multiple drugs to treat various symptoms ...

Although VDZ is a front-line drug and has been successfully prescribed around the world, its broader mechanism of action has remained unclear. The drug works by binding to the cellular site that it ...

Understanding a drug’s mechanism of action (MOA) can greatly increase the likelihood of successful clinical trials by identifying biomarkers of patient response and providing a rationale for ...